Hs-C-reactive protein (hs-CRP) levels were similar between normal IMT patients and patients with pathological IMTs (nIMT 1.4 mg/L [IQR: 0.5–3] vs. pIMT 1.1 mg/L [IQR: 0.5–3.25], p = .41; Fig. 3D). The gene discussed is CRP; the disease is inflammatory myofibroblastic tumor.